Literature DB >> 30529372

Beware of Clinical Trials of DNA Repair Inhibitors.

J Martin Brown1.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 30529372     DOI: 10.1016/j.ijrobp.2018.11.063

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

1.  Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases.

Authors:  Surabhi Talele; Wenjuan Zhang; Ju-Hee Oh; Danielle M Burgenske; Ann C Mladek; Sonja Dragojevic; Jann N Sarkaria; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2022-04-03       Impact factor: 4.402

2.  Nonhomologous End Joining Is More Important Than Proton Linear Energy Transfer in Dictating Cell Death.

Authors:  Scott J Bright; David B Flint; Sharmistha Chakraborty; Conor H McFadden; David S Yoon; Lawrence Bronk; Uwe Titt; Radhe Mohan; David R Grosshans; Pavel Sumazin; Simona F Shaitelman; Aroumougame Asaithamby; Gabriel O Sawakuchi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-08-16       Impact factor: 7.038

Review 3.  Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting.

Authors:  Julian Biau; Emmanuel Chautard; Pierre Verrelle; Marie Dutreix
Journal:  Front Oncol       Date:  2019-10-10       Impact factor: 6.244

Review 4.  Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy.

Authors:  Daniel Czajkowski; Radosław Szmyd; Harriet E Gee
Journal:  J Med Imaging Radiat Oncol       Date:  2022-04-23       Impact factor: 1.667

Review 5.  Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.

Authors:  Charleen M L Chan Wah Hak; Antonio Rullan; Emmanuel C Patin; Malin Pedersen; Alan A Melcher; Kevin J Harrington
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

Review 6.  Therapeutic targeting of the hypoxic tumour microenvironment.

Authors:  Dean C Singleton; Andrew Macann; William R Wilson
Journal:  Nat Rev Clin Oncol       Date:  2021-07-29       Impact factor: 66.675

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.